Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-790052 + PegIFN/RBV in Japanese HCV GT1
NCT01016912Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daclatasvir in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Started Dec 2009; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01016912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016912.